BACKGROUND: Several clinical studies have evaluated the association between galectin-3 levels and outcome in patients with heart failure (HF). However, little is known about the predictive value of repeated galectin-3 measurements. This study evaluates the prognostic value of repeated time-dependent galectin-3 measurements in acute HF patients.METHODS AND RESULTS: In the TRIUMPH (Translational Initiative on Unique and Novel Strategies for Management of Patients with Heart Failure) clinical cohort study, 496 acute HF patients were enrolled in 14 hospitals in The Netherlands, between 2009 and 2014. Repeated blood samples (7) were drawn during 1-year follow-up. Associations between repeated biomarker measurements and the primary end point were...
Heart failure (HF) is a leading cause of mortality in the western world. Despite advances in the tre...
Biomarkers are increasingly being used in the management of patients with chronic heart failure (HF)...
SummaryHeart failure constitutes an important medical, social and economic problem. The prevalence o...
BACKGROUND: Several clinical studies have evaluated the association between galectin-3 levels and ou...
Background--Several clinical studies have evaluated the association between galectin-3 levels and ou...
Background-In several cross-sectional analyses, circulating baseline levels of galectin-3, a protein...
Background Rehospitalization is a major cause for heart failure (HF)-related morbidity and is associ...
Background Lifetime risk for cardiovascular (CV) disease is high but predicting incident events on a...
BackgroundRehospitalization is a major cause for heart failure (HF)–related morbidity and is associa...
[[abstract]]Background: Galectin-3, a marker of cardiac fibrosis, is an emergent prognostic biomarker...
Aims: Galectin-3 (Gal-3) predicts long-term outcome among patients with heart failure (HF) with pres...
Biomarkers are increasingly being used in the management of patients with chronic heart failure (HF)...
Heart failure (HF) is a leading cause of mortality in the western world. Despite advances in the tre...
Biomarkers are increasingly being used in the management of patients with chronic heart failure (HF)...
SummaryHeart failure constitutes an important medical, social and economic problem. The prevalence o...
BACKGROUND: Several clinical studies have evaluated the association between galectin-3 levels and ou...
Background--Several clinical studies have evaluated the association between galectin-3 levels and ou...
Background-In several cross-sectional analyses, circulating baseline levels of galectin-3, a protein...
Background Rehospitalization is a major cause for heart failure (HF)-related morbidity and is associ...
Background Lifetime risk for cardiovascular (CV) disease is high but predicting incident events on a...
BackgroundRehospitalization is a major cause for heart failure (HF)–related morbidity and is associa...
[[abstract]]Background: Galectin-3, a marker of cardiac fibrosis, is an emergent prognostic biomarker...
Aims: Galectin-3 (Gal-3) predicts long-term outcome among patients with heart failure (HF) with pres...
Biomarkers are increasingly being used in the management of patients with chronic heart failure (HF)...
Heart failure (HF) is a leading cause of mortality in the western world. Despite advances in the tre...
Biomarkers are increasingly being used in the management of patients with chronic heart failure (HF)...
SummaryHeart failure constitutes an important medical, social and economic problem. The prevalence o...